New Treatment Could Be 'Breakthrough' for Vitiligo

The new therapy includes the oral medication Xeljanz (tofacitinib) -- a drug already approved for use in rheumatoid arthritis patients that dampens the body's immune response -- and ultraviolet-B light therapy.
Source: WebMD Health - Category: Consumer Health News Source Type: news